China's SFDA Following through on GMP Efforts

Since China's State Food and Drug Administration (SFDA) revised its GMPs last year (they became effective Mar. 1, 2011), the agency has been making other improvements to enhance the quality of its pharmaceutical manufacturing industry. Many improvements are tied to the 2015 deadline SFDA has placed on existing domestic drug manufacturers to implement the revised guidelines. Newly created companies are expected to meet the new GMPs from the start.

Recent announcements on the SFDA website (eng.sfda.gov.cn) note ongoing changes and requirements. For example, SFDA is working to strengthen the way it manages drug GMP inspections by standardizing its inspection and certification …